Mehdi Tourani

Mehdi Tourani

Auto-generated profile, based on publicly available information

Mehdi Tourani

11Health Research Institute, Babol University of Medical Sciences, Babol, Iran

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 July 2020 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
MRMaryam Rostamtabar
Maryam Rostamtabar
SESedigheh Esmaeilzadeh
Sedigheh Esmaeilzadeh
MTMehdi Tourani
Mehdi Tourani
ARAbolfazl Rahmani
Abolfazl Rahmani
MBMasoud Baee
Masoud Baee
HNHamid Reza Nouri
Hamid Reza Nouri

1 January 2022 in International Journal Of Clinical Practice
Verified
Journal Article
Open access
PDF file
FSFarzin Sadeghi
Farzin Sadeghi
APAbazar Pournajaf
Abazar Pournajaf
MHMehrdad Halaji
Mehrdad Halaji
MCMohammad Chehrazi
Mohammad Chehrazi
FAFatemeh Hejazi Amiri
Fatemeh Hejazi Amiri
YYYousef Yahyapour
Yousef Yahyapour
Objectives. To avoid worsening from mild, moderate, and severe diseases and to reduce mortality, it is necessary to identify the subpopulation that is more vulnerable to the development of COVID‐19 unfavorable consequences. This study aims to investigate the demographic information, prevalence rates of common comorbidities among negative and positive real‐time reverse‐transcriptase polymerase chain reaction (rRT‐PCR) patients, and the association between SARS‐CoV‐2 cycle threshold (Ct) at hospital admission, demographic data, and outcomes of the patients in a large population in Northern Iran. Methods. This large retrospective cross‐sectional study was performed from 7 March to 20 December 2020. Demographic data, including gender, age, underlying diseases, clinical outcomes, and Ct values, were obtained from 8,318 cases suspected of COVID‐19, who were admitted to four teaching hospitals affiliated to Babol University of Medical Sciences (MUBABOL), in the north of Iran. Results. Since 7 March 2020, the data were collected from 8,318 cases suspected of COVID‐19 (48.5% female and 51.5% male) with a mean age of 53 ± 25.3 years. Among 8,318 suspected COVID‐19 patients, 3,250 (39.1%) had a positive rRT‐PCR result; 1,632 (50.2%) patients were male and 335 (10.3%) patients died during their hospital stay. The distribution of positive rRT‐PCR revealed that most patients (464 (75.7%)) had a Ct between 21 and 30 (Group B). Conclusion. Elderly patients, lower Ct, patients having at least one comorbidity, and male cases were significantly associated with increased risk for COVID‐19‐related mortality. Moreover, mortality was significantly higher in patients with diabetes, kidney disease, and respiratory disease.

1 December 2021 in Transfusion and Apheresis Science
Verified
Journal Article
Closed access
AFArad Aghaie Fard
Arad Aghaie Fard
MTMehdi Tourani
Mehdi Tourani
FHFatemeh Heydari
Fatemeh Heydari
SNShahryar Khoshtinat Nikkhoi
Shahryar Khoshtinat Nikkhoi
HHHedieh Heydarzadeh
Hedieh Heydarzadeh
MTMortaza Taheri-Anganeh
Mortaza Taheri-Anganeh